LifeMine Therapeutics

Series-B+
lifeminetx.com Biotech & Healthcare Cambridge, United States Founded 2016 101-250
Total Funding $543M
Latest Round $75M Series-B+
Last Announced Aug 6, 2026
Investors 19 Backers
Decision Makers 6 Verified

About LifeMine Therapeutics

LifeMine is a clinical-stage biopharmaceutical company pioneering a bold new approach, Top-Down Drug DiscoveryTM, which leverages evolutionary insights from fungi to unearth next-generation precision medicines.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-B+
Global Headquarters Cambridge, United States
Year Founded 2016
Team Size 101-250
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website lifeminetx.com
Domain Registered Date Aug 1, 2016

Social & Network Presence

X / Twitter Profile @LifeMineTx (5 followers) Created on Mar 2019
LinkedIn Corporate Not linked

Company Milestones & Timeline

8 Events
  1. Capital Raise

    Raised $75,000,000 · Series-B+

  2. Capital Raise

    Raised $188,000,000 · Series-B+

    fundraisingfox.com

  3. Capital Raise

    Raised $175,000,000 · Series-B+

    fundraisingfox.com

  4. Capital Raise

    Raised $50,000,000 · Series-B+

  5. Milestone

    X account created (@LifeMineTx)

    5 followers

  6. Capital Raise

    Raised $55,000,000 · Series-A

  7. Milestone

    Website domain registered

    lifeminetx.com

  8. Milestone

    Company founded

    Cambridge, United States

Investors & Backers

19
3W Partners Capital
Alexandria Venture Investments
ARCH Venture Partners
Bezos Expeditions
Blue Pool Capital
Boyu Capital
Fidelity Management & Research Company
Foresite Capital
Gates Frontier
GlaxoSmithKline
GSK
GV
Invus
LoLa Capital Partners
Milky Way Investments
MRL Ventures Fund
RA Capital Management
Rick Klausner
WuXi Healthcare Ventures

Funding History

5 Rounds
Series-B+ · Aug 6, 2026
$75,000,000 Source
Series-B+ · Aug 6, 2026
Series-B+ · Mar 23, 2022
Series-B+ · Jan 7, 2021
$50,000,000 Source
Series-A · Sep 18, 2017
$55,000,000 Source

Founders & Leadership

11

Gregory Verdine

Founder

Work email & phone locked Unlock →

Hingge Hsu

Founder

Work email & phone locked Unlock →

Hongyue Dai

VP, Translational Bioinformatics

Work email & phone locked Unlock →

Jared Cumming

SVP & Head of Chemistry

Work email & phone locked Unlock →

Karen Guarco

Senior Vice President of Finance and Research Operations of Finance

Work email & phone locked Unlock →

Martin Stahl

Chief Scientific Officer

Work email & phone locked Unlock →

Paola Castaldi

Vice President of Chemical Biology & Proteomics

Work email & phone locked Unlock →

Rick Klausner

Founder

Work email & phone locked Unlock →

Tom Ramseier

VP of Synthetic Biology

Work email & phone locked Unlock →

Weiqing Zhou

Founder

Work email & phone locked Unlock →

Yves Zinggeler

Chief Commercial Officer

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts